Human dengue virus serotype 2 neutralizing antibodies target two distinct quaternary epitopes

• Emily N. Gallichotte,

  Roles Conceptualization, Investigation, Methodology, Writing – original draft, Writing – review & editing

  Affiliation Department of Microbiology and Immunology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, United States of America

  ⨯
• Thomas J. Baric,

  Roles Investigation

  Affiliation Department of Epidemiology, University of North Carolina at Chapel Hill School of Public Health, Chapel Hill, North Carolina, United States of America

  ⨯
• Boyd L. Yount Jr,

  Roles Investigation

  Affiliation Department of Epidemiology, University of North Carolina at Chapel Hill School of Public Health, Chapel Hill, North Carolina, United States of America

  http://orcid.org/0000-0002-6099-8429

  ⨯
• Douglas G. Widman,

  Roles Investigation

  Affiliation Department of Epidemiology, University of North Carolina at Chapel Hill School of Public Health, Chapel Hill, North Carolina, United States of America

  ⨯
• Anna Durbin,

  Roles Resources, Writing – review & editing

  Affiliation Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America

  http://orcid.org/0000-0002-6652-2851

  ⨯
• Steve Whitehead,

  Roles Resources, Writing – review & editing

  Affiliation Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Ralph S. Baric ,

  Roles Conceptualization, Funding acquisition, Resources, Supervision, Writing – review & editing

  * E-mail: rbaric@email.unc.edu (RSB); aravinda_desilva@med.unc.edu (AMdS)

  Affiliations Department of Microbiology and Immunology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, United States of America, Department of Epidemiology, University of North Carolina at Chapel Hill School of Public Health, Chapel Hill, North Carolina, United States of America

  ⨯
• Aravinda M. de Silva

  Roles Conceptualization, Funding acquisition, Resources, Supervision, Writing – review & editing

  * E-mail: rbaric@email.unc.edu (RSB); aravinda_desilva@med.unc.edu (AMdS)

  Affiliation Department of Microbiology and Immunology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, United States of America

  ⨯